Table 1 Baseline characteristics before sintilimab treatment
Case | Sex | Age (m) | Weight (kg) | Clinical manifestation | Disease duration | Primary treatment | Diagnosis |
|---|---|---|---|---|---|---|---|
1 | M | 74 | 16 | Intermittent fever Hepatosplenomegaly liver function abnormalities lymphadenopathy | More than 4 years | Antiviral drugs IVIG Methylprednisolone | CAEBV |
2 | F | 150 | 26.7 | Intermittent fever Intermittent skin rash Oral ulcer lymphadenopathy | More than 6 years | Antiviral drugs | CAEBV |
3 | M | 50 | 15.5 | Intermittent fever Intermittent skin rash Mild abdominal pain lymphadenopathy | More than 1 month | Antiviral drugs IVIG Methylprednisolone pulse | EBV-HLH |